CoapTech LLC Awarded $1.2M Grant from National Institutes of Health to Support Clinical Evaluation and Training for Novel PUMA-G Device BALTIMORE, Md., Oct. 21, 2019 (GLOBE NEWSWIRE) -- CoapTech LLC announced today that the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) within the National Institutes of...

Lentigen Technology Inc., a Miltenyi Biotec Company, Acquires University of Maryland, Baltimore CAR-T Cell Start-Up, Living Pharma, Inc. Lentigen Technology Inc., a leading provider of GMP lentiviral vectors, will further advance Living Pharma’s personalized chimeric antigen receptor (CAR) T-cell therapies targeting various...

UM Baltimore Grants Pataigin, LLC, Rights to Technology Developed for Rapid, Point-Of-Care Identification of Dangerous Pathogens BALTIMORE, Dec. 08, 2015 (GLOBE NEWSWIRE) -- University of Maryland (UM) Ventures and Pataigin, LLC, announced today that the University of Maryland, Baltimore (UMB) has granted Pataigin worldwide,...

Educational & Scientific, LLC and University of Maryland, Baltimore Sign an Agreement to Develop and Commercialize Novel Treatment for Major Cancers BALTIMORE, Oct. 28, 2015 (GLOBE NEWSWIRE) -- University of Maryland (UM) Ventures and Educational and Scientific LLC (ESL), announced today that the University of Maryland, Baltimore (UMB) granted...

UM Baltimore Grants Glycocept Rights to a Technology Designed to Increase the Efficacy of Therapeutic Monoclonal Antibodies BALTIMORE, Oct. 28, 2015 (GLOBE NEWSWIRE) -- University of Maryland (UM) Ventures and Glycocept, Inc. announced today that the University of Maryland, Baltimore (UMB) has granted Glycocept...